✦ LIBER ✦

Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities

✍ Scribed by Lund, Asger; Knop, Filip K.; Vilsbøll, Tina

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of type 2 diabetes with glucag

✍ K. B. Hansen; F. K. Knop; J. J. Holst; T. Vilsbøll 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

The development of non-peptide glucagon-

✍ Ho-Sang Moon; Mi-Kyung Kim; Moon-Ho Son 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 620 KB

Incretin-based treatment of type 2 diabe

✍ Carolyn F. Deacon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Early use of glucagon-like peptide-1 rec

✍ Ross, Stuart A.; Ballantine, Jane 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 586 KB

A glucagon-like peptide-1 (GLP-1) recept

✍ S. K. Thondam; D. J. Cuthbertson; B. S. Aditya; I. A. MacFarlane; J. P. Wilding; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Incretin-based Therapies (Glucagon-like

✍ Amir Hanna; Vincent Woo; Jean-François Yale; Elaine M. Cooke 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 208 KB